Ching‐Chow Chen
Impact in
- Cancer Research top 1%
- NF-κB Signaling Pathways
- Immunology top 2%
- Immune Response and Inflammation
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 12
- Histone Deacetylase Inhibitors Research 12
- Receptor Mechanisms and Signaling 8
-
- NF-κB Signaling Pathways 18
- Co-authors
- Wei‐Chien Huang (12 shared papers)Ming‐Shiang Wu (12 shared papers)Ya‐Jen Chang (10 shared papers)Chia‐Tung Shun (7 shared papers)Shwu‐Bin Lin (3 shared papers)Junjie Chen (3 shared papers)Yi-Chu Lin (3 shared papers)Junjie Chen (4 shared papers)
- Journals
- Molecular Pharmacology (11 papers)The Journal of Immunology (6 papers)Oncotarget (5 papers)European Journal of Pharmacology (5 papers)Journal of Biological Chemistry (5 papers)
- Partner nations
- TaiwanUnited StatesCzechia
In The Last Decade
Ching‐Chow Chen
102 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 1.1k
- Immunology 1.1k
- Molecular Biology 2.7k
- Physiology 177
- Oncology 845
Countries citing papers authored by Ching‐Chow Chen
This map shows the geographic impact of Ching‐Chow Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chow Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chow Chen more than expected).
Fields of papers citing papers by Ching‐Chow Chen
This network shows the impact of papers produced by Ching‐Chow Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chow Chen. The network helps show where Ching‐Chow Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Chow Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 287 | |
| 2 | 2005 | 245 | |
| 3 | 2004 | 230 | |
| 4 | 2007 | 204 | |
| 5 | 2010 | 189 | |
| 6 | 2018 | 186 | |
| 7 | 2000 | 180 | |
| 8 | 2008 | 161 | |
| 9 | 2005 | 137 | |
| 10 | 2004 | 137 | |
| 11 | 2010 | 132 | |
| 12 | 2006 | 121 | |
| 13 | 2003 | 119 | |
| 14 | 2004 | 117 | |
| 15 | Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. | 1998 | 116 |
| 16 | 2001 | 115 | |
| 17 | 2003 | 110 | |
| 18 | 2016 | 108 | |
| 19 | 1999 | 107 | |
| 20 | 1998 | 103 |
About Ching‐Chow Chen
Ching‐Chow Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pharmacology, having authored 102 papers that have together received 5.8k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (18 papers), Protein Kinase Regulation and GTPase Signaling (12 papers), Histone Deacetylase Inhibitors Research (12 papers), Nitric Oxide and Endothelin Effects (9 papers), Inflammatory mediators and NSAID effects (9 papers), Receptor Mechanisms and Signaling (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (1.1k citations), Molecular Biology (2.7k citations), Physiology (177 citations) and Oncology (845 citations). Ching‐Chow Chen has collaborated with scholars based in Taiwan, United States and Czechia. Frequent co-authors include Wei‐Chien Huang, Ming‐Shiang Wu, Ya‐Jen Chang, Chia‐Tung Shun, Shwu‐Bin Lin, Junjie Chen, Yi-Chu Lin, Junjie Chen, Chia‐Wei Chou and Mien‐Chie Hung. Their work appears in journals such as Molecular Pharmacology, The Journal of Immunology, Oncotarget, European Journal of Pharmacology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.